As the medical community is growing studies and research on the use of psychedelic drugs for use in treating mental health concerns. Research has shown they can improve the symptoms of PTSD, depression, and some other mental health issues. Most of these studies have considered the use of LSD and mushrooms, though there are others, and as the research grows there are more companies that are going public with their stock offerings.
This may be an opportunity for investment for any investors who are looking for new opportunities that are growing quickly, new companies and markets, that are forming, and who are interested in the topic. As only a few companies have released IPOs there is a small market so far, but it is growing quickly and as more uses and benefits are found it may grow more. Like every stock there are risks and benefits, many unknowns, and it is suited for investors who are willing and able to take the risk on it. Much of the risk with this particular choice is the unknown of how the government and the legalization processes are going to affect it, if these products become legalized and prescribed or allowed for medical use the market will grow quickly and the returns will be high, however if they find high risks or side affects, or it does not become legal, then money may be lost.
There are three main companies that are active; Champignon Brands, Mind Medicine, and Hollister Biosciences.
When choosing where to invest your money learn what you can about each before investing or find an advisor you trust.
Champignon is involved in the development of new medications, focused on magic mushrooms, to treat a variety of mental health concerns and to help relieve symptoms and return people back to living regular lives. They have a very strong research team, and they are holding several intellectual property ideas and medications preparing for release. Mind Medicine has several clinical trials in various stages and holds a focus on LSD for long term solutions and the backing to complete all the trials in place which make them a big player in this market. Hollister Biosciences is an established cannabis distributor that has expanded into psychedelics allowing the cannabis to carry the business while they grow. This makes them a safer investment for those with a low risk threshold.
As research grow and more companies are entering the space now is a great chance for those interested in the space to get involved at the beginning. This can offer the greatest opportunities for returns but may risk the largest loses as well, with so much hinging on what laws will be passed in the future. When looking to invest it is important to know your comfort level for risk, learn about the companies you are considering, and don’t wait too long to make your move. The research has been showing positive results, and it can be a change to enter a new space that might just help a lot of people with their health needs while bringing in a return on your investment.
